| Literature DB >> 30637921 |
Ruth Cleaver1,2, Jonathan Berg3, Emily Craft4, Alison Foster5, Richard J Gibbons6, Emma Hobson7, Katherine Lachlan8,9, Swati Naik5, Julian R Sampson10, Saba Sharif5, Sarah Smithson11, Michael J Parker12, Katrina Tatton-Brown1,13.
Abstract
Primrose syndrome is a rare autosomal dominant condition caused by heterozygous missense variants within ZBTB20. Through an exome sequencing approach (as part of the Deciphering Developmental Disorders [DDD] study) we have identified five unrelated individuals with previously unreported, de novo ZBTB20 pathogenic missense variants. All five missense variants targeted the C2H2 zinc finger domains. This genotype-up approach has allowed further refinement of the Primrose syndrome phenotype. Major characteristics (>90% individuals) include an intellectual disability (most frequently in the moderate range), a recognizable facial appearance and brain MRI abnormalities, particularly abnormalities of the corpus callosum. Other frequent clinical associations (in 50-90% individuals) include sensorineural hearing loss (83%), hypotonia (78%), cryptorchidism in males (75%), macrocephaly (72%), behavioral issues (56%), and dysplastic/hypoplastic nails (57%). Based upon these clinical data we discuss our current management of patients with Primrose syndrome.Entities:
Keywords: DDD study; Primrose syndrome; ZBTB20; exome sequencing; intellectual disability
Mesh:
Substances:
Year: 2019 PMID: 30637921 DOI: 10.1002/ajmg.a.61024
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802